Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
CYTK — Cytokinetics, Incorporated
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 5, 2026
REVENUE
$19.4M +9.0%
NET MARGIN
-1064.5% -33.6 PTS
EPS
-$1.67 -12.1%
FREE CASH FLOW
-$151.4M -2.1%

No summary has been written for this call yet.